Market Intelligence Center  Jun 3  Comment 
For a hedged play on Align Technology Inc (ALGN), MarketIntelligenceCenter.com’s option-trade picking algorithms recommend the Oct. '15 $60.00 covered call for a net debit in the $57.17 area. That is also the break-even stock price for the...
Market Intelligence Center  May 15  Comment 
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on Align Technology Inc (ALGN) that includes 11.63% downside protection. Sell one contract of the...
Market Intelligence Center  May 12  Comment 
Align Technology Inc (ALGN) traded between $59.23 and $59.91 before closing at $59.35 Monday and presents some attractive trading opportunities today. MarketIntelligenceCenter.com’s patented algorithms selected a Oct. '15 $55.00 covered call for...
Market Intelligence Center  May 4  Comment 
MarketIntelligenceCenter.com's patented trade-picking algorithms have identified an attractive covered-call trade on Align Technology Inc (ALGN). Look at the Oct. '15 $55.00 covered call for a net debit in the $52.38 area. This trade has a...
Market Intelligence Center  Apr 30  Comment 
Align Technology Inc (ALGN) presents a trading opportunity that offers a 3.66% return in just 50 days. A covered call on Align Technology at the $60.00 level expiring on Jun. '15 offers an assigned return rate of 3.66% or 26.74% annualized. This...
Motley Fool  Apr 23  Comment 
Align Technology shareholders are smiling after strong Q1 revenue and earnings.
Market Intelligence Center  Apr 23  Comment 
Align Technology Inc (ALGN) traded between $55.41 and $56.26 before closing at $55.94 Wednesday and presents some attractive trading opportunities today. MarketIntelligenceCenter.com’s patented algorithms selected a Jun. '15 $55.00 covered call...
Benzinga  Apr 21  Comment 
Morgan Stanley upgraded Align Technology, Inc. (NASDAQ: ALGN) from Equal-weight to Overweight. The price target for Align Technology has been raised from $56.00 to $79.00. Align Technology shares have gained 4.13 percent over the past 52...


Related Articles


Align Technology, Inc., founded in 1997, is engaged in the design, manufacture, and marketing of Invisalign, a proprietary system for treating malocclusion, or crooked teeth. The Invisalign product has two components, ClinCheck and Aligners. ClinCheck is an Internet-based application that allows dental professionals to simulate treatment in three dimensions, by modeling two-week stages of tooth movement. Aligners are thin, clear-plastic, removable dental appliances that are manufactured in a series to correspond to each two-week stage of the ClinCheck simulation. Aligners are customized to perform the treatment prescribed for an individual patient by dental professionals using ClinCheck. Invisalign is approved to treat patients, with any type of malocclusion, with mature upper and lower tooth structures. The company voluntarily restricts the use of Invisalign to adults and adolescents with immature structures. Typically, permanent structures occur in the later-teen years. Align does not treat children whose teeth and jaws are still developing, as the effectiveness of Invisalign relies on the company's ability to accurately predict the movement of teeth over the course of treatment. Based on its clinical studies to date, Align recommends that dental professionals use Invisalign as a complete treatment for a range of malocclusions, and as a component of treatment for severe malocclusions.

Internationally, the company operates in the regions of Europe, Asia/Pacific, and Latin America. At the end of 2007, sales in the domestic orthodontist channel represented 30% of total revenues, while sales in the domestic general practitioner (GP) channel represented 46%, and the international channel represented 20%. The remaining 5% came from education training and other revenues.


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki